Filtered by:
46 Programs
-
ASCO 2026 Satellite
Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway in Breast Cancer
-
-
E
-
J
-
N
- +2
-
E
-
-
Nursing Symposium
Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer
-
-
K
-
M
-
R
- +1
-
K
-
-
Nursing Symposium
Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer
-
-
K
-
M
-
R
- +1
-
K
-